Akoustis Technologies (NASDAQ: AKTS) shares are trading higher after the company announced it received a volume commercial order for its patented WiFi 6 XBAWTM filters from its second WiFi 6 OEM customer. The company said thr first shipments will begin in the current quarter.
Akari Therapeutics, Plc (NASDAQ:AKTX) ("Akari" or the "Company"), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the
Akoustis Technologies, Inc. (NASDAQ:AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless
Gainers
Aware (NASDAQ:AWRE) stock increased by 7.59% to $4.11 during Wednesday's after-market session. Trading volume for this security closed at 467, accounting for 1.0% of its average full-day volume over the last 100 days. The company's market cap stands at $88.3 million.